StonvexLoading…
StonvexStonvexStonvexCore line items from EDIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $40.52M | $32.31M | $78.12M | $19.71M |
Operating Income | $-160.01M | $-251.15M | $-169.18M | $-225.95M |
Net Income | $-160.06M | $-237.09M | $-153.22M | $-220.43M |
EPS (Diluted) | $-1.80 | $-2.88 | $-2.02 | $-3.21 |
Total Assets | $186.53M | $341.59M | $499.15M | $514.32M |
Total Liabilities | $159.25M | $207.31M | $150.06M | $153.64M |
Cash & Equivalents | $146.65M | $131.54M | $123.65M | $141.52M |
Free Cash Flow OCF − CapEx | $-165.85M | $-219.11M | $-136.90M | $-181.47M |
Shares Outstanding | 97.87M | 82.73M | 81.77M | 68.85M |